Multi-center Phase I/II Study of NY-ESO-1 T Cell Receptor Gene Transferred T Lymphocytes in Patients With Synovial Sarcoma
Phase of Trial: Phase I/II
Latest Information Update: 10 Apr 2018
At a glance
- Drugs NTBI 1301 (Primary) ; Cyclophosphamide
- Indications Synovial sarcoma
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Takara Bio
- 17 Jan 2018 According to a Takara Bio media release, the first patient has been enrolled in Japan on January 15-16, 2018.
- 12 Oct 2017 Status changed from not yet recruiting to recruiting.
- 16 Aug 2017 New trial record